Journal
MEDICAL HYPOTHESES
Volume 167, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.mehy.2022.110948
Keywords
SARS-CoV-2; Drug; Lipopeptide surfactant; Lipid envelope; Spike protein; ACE-2
Categories
Ask authors/readers for more resources
Finding effective drugs to treat SARS-CoV-2 infection is crucial in overcoming the current pandemic. Research has shown that certain bio-active unsaturated fatty acids and designed peptides may reduce infection severity, destroy the virus, and inhibit viral replication.
Finding effective drugs to treat SARS-CoV-2 infection as a complementary step to the extensive vaccination is of the great importance to overcome the current pandemic situation. It has been shown that some bio-active un-saturated fatty acids such as Arachidonic Acid (AA) can reduce the infection severity and even destroy the virus by disintegration of the virus lipid envelope. On the other hand, it has been reported that several designed peptides with an activity similar to the angiotensin converting enzyme 2 (ACE-2), which has a high affinity towards the novel corona virus spike protein, can inhibit the viral infection through concealing the spike proteins from the cell surfaces ACE-2. Binding the mentioned peptides to the bio-active lipids like AA will result in a lipopeptide surfactant molecule with the synergistic effect of both the active moieties in its structure to treat the novel corona infection. In addition, the peptide segment increases the aqueous solubility of the lipid segment and enables the targeted delivery of the surfactant molecule to the virus. The resultant lipopeptide would be a potentially effective drug for SARS-CoV-2 infection treatment with the minimum side effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available